News

Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...
Doctors and genetic researchers at The University of Manchester have discovered that changes in a gene leads to severe nerve damage in children following a mild bout of infection.
New research shows COVID-19 raises the risk of Guillain-Barré syndrome more than vaccines. mRNA vaccines pose no increased risk, global data reveals.
Valley man spreading awareness about Guillain-Barré Syndrome Guillain-Barré Syndrome is a condition that attacks a person's nerves. It can lead to muscle weakness and sometimes paralysis.
OBJECTIVE To identify clinical characteristics of various forms of Guillain-Barré syndrome in Taiwan. METHODS The clinical and electrophysiological data of 167 consecutive patients with Guillain-Barré ...
SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III ...
Annexon’s investigational antibody tanruprubart can improve functional outcomes in patients with Guillain-Barré syndrome as early as one week into treatment, according to a Phase III readout on ...
As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another effort to improve treatment of the rare condition. | As it advances a ...
About Guillain-Barré Syndrome GBS is a rare neuromuscular emergency resulting from an acute autoantibody and classical complement-mediated attack on peripheral nerves that generally occurs ...
Scientists have linked Zika firmly to Guillain-Barré syndrome, known for triggering temporary paralysis.